Particle News: Latest CVS Caremark news

FDA Ends GLP-1 Drug Shortages, Triggering New Pricing and Coverage Moves

Novo Nordisk and Cigna introduce temporary discounts and copay caps as compounded semaglutide distribution ceases under new FDA regulations.

Novo Nordisk Revises 2025 Outlook as FDA Crackdown and Competition Reshape Wegovy Market

WHO to Endorse GLP-1 Weight-Loss Drugs, Calls for Global Access

Congress Examines Pharmacy Benefit Managers in Push to Lower Drug Costs

FTC Report Reveals $7.3 Billion in Drug Markups by Leading PBMs

Trump Targets Drug Industry Middlemen, Sending CVS, UnitedHealth, and Cigna Shares Lower

Bipartisan Bill Targets Pharmacy Benefit Manager Consolidation

Texas Sues Insulin Manufacturers and PBMs for Price Inflation

FTC Sues Top Pharmacy Benefit Managers Over Inflated Insulin Prices

Pharmacy Benefit Managers Under Fire for Inflating Drug Costs

Blue Shield of California partners with Amazon, Mark Cuban's Cost Plus Drugs to overhaul pharmacy benefits system